| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 1.39e-06 | 25 | 67 | 4 | GO:0017056 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 1.92e-06 | 27 | 67 | 4 | GO:0008139 | |
| GeneOntologyMolecularFunction | signal sequence binding | 2.57e-05 | 51 | 67 | 4 | GO:0005048 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 4.87e-04 | 417 | 67 | 7 | GO:0061629 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 7.13e-04 | 582 | 67 | 8 | GO:0140297 | |
| GeneOntologyBiologicalProcess | nuclear pore organization | 2.58e-05 | 18 | 67 | 3 | GO:0006999 | |
| GeneOntologyBiologicalProcess | ureteric peristalsis | 3.11e-05 | 3 | 67 | 2 | GO:0072105 | |
| GeneOntologyBiologicalProcess | ureter smooth muscle contraction | 3.11e-05 | 3 | 67 | 2 | GO:0014849 | |
| GeneOntologyBiologicalProcess | mammary placode formation | 6.21e-05 | 4 | 67 | 2 | GO:0060596 | |
| GeneOntologyBiologicalProcess | atrioventricular canal morphogenesis | 1.03e-04 | 5 | 67 | 2 | GO:1905222 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | CREBRF TBX3 GLIS2 PLAGL1 CTBP1 MACROH2A2 MAPK10 ASCL3 SPEN CNOT1 DNMT1 TBX2 | 1.31e-04 | 1053 | 67 | 12 | GO:0000122 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | CREBRF TBX3 GLIS2 PLAGL1 CTBP1 MACROH2A2 ZNF318 MAPK10 ASCL3 TRIM24 SPEN CNOT1 DNMT1 TBX2 | 1.33e-04 | 1399 | 67 | 14 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | CREBRF TBX3 GLIS2 PLAGL1 CTBP1 MACROH2A2 ZNF318 MAPK10 ASCL3 TRIM24 SPEN CNOT1 DNMT1 TBX2 | 1.48e-04 | 1413 | 67 | 14 | GO:1902679 |
| GeneOntologyBiologicalProcess | endocardial cushion formation | 1.52e-04 | 32 | 67 | 3 | GO:0003272 | |
| GeneOntologyBiologicalProcess | cardiac jelly development | 1.55e-04 | 6 | 67 | 2 | GO:1905072 | |
| Domain | TBX | 1.08e-05 | 2 | 62 | 2 | IPR022582 | |
| Domain | TBX | 1.08e-05 | 2 | 62 | 2 | PF12598 | |
| Domain | La | 2.25e-04 | 7 | 62 | 2 | PF05383 | |
| Domain | LA | 2.25e-04 | 7 | 62 | 2 | SM00715 | |
| Domain | Lupus_La_RNA-bd | 2.25e-04 | 7 | 62 | 2 | IPR006630 | |
| Domain | HTH_LA | 2.25e-04 | 7 | 62 | 2 | PS50961 | |
| Domain | TF_T-box | 1.43e-03 | 17 | 62 | 2 | IPR001699 | |
| Domain | TBOX | 1.43e-03 | 17 | 62 | 2 | SM00425 | |
| Domain | TF_T-box_CS | 1.43e-03 | 17 | 62 | 2 | IPR018186 | |
| Domain | - | 1.43e-03 | 17 | 62 | 2 | 2.60.40.820 | |
| Domain | TBOX_3 | 1.43e-03 | 17 | 62 | 2 | PS50252 | |
| Domain | T-box | 1.43e-03 | 17 | 62 | 2 | PF00907 | |
| Domain | TBOX_1 | 1.43e-03 | 17 | 62 | 2 | PS01283 | |
| Domain | TBOX_2 | 1.43e-03 | 17 | 62 | 2 | PS01264 | |
| Domain | Bromodomain_CS | 3.35e-03 | 26 | 62 | 2 | IPR018359 | |
| Domain | BROMODOMAIN_1 | 6.70e-03 | 37 | 62 | 2 | PS00633 | |
| Domain | Bromodomain | 7.06e-03 | 38 | 62 | 2 | PF00439 | |
| Domain | - | 7.42e-03 | 39 | 62 | 2 | 2.120.10.30 | |
| Domain | BROMODOMAIN_2 | 8.18e-03 | 41 | 62 | 2 | PS50014 | |
| Domain | BROMO | 8.57e-03 | 42 | 62 | 2 | SM00297 | |
| Domain | Bromodomain | 8.57e-03 | 42 | 62 | 2 | IPR001487 | |
| Domain | - | 8.57e-03 | 42 | 62 | 2 | 1.20.920.10 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.16e-05 | 40 | 50 | 4 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.29e-05 | 41 | 50 | 4 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.42e-05 | 42 | 50 | 4 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 1.56e-05 | 43 | 50 | 4 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 2.23e-05 | 47 | 50 | 4 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 2.64e-05 | 49 | 50 | 4 | MM14837 | |
| Pathway | REACTOME_SUMOYLATION | 2.79e-05 | 169 | 50 | 6 | MM14919 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 2.86e-05 | 50 | 50 | 4 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 3.09e-05 | 51 | 50 | 4 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 4.18e-05 | 55 | 50 | 4 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 5.16e-05 | 58 | 50 | 4 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 5.16e-05 | 58 | 50 | 4 | MM14736 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 8.06e-05 | 24 | 50 | 3 | MM15658 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 8.08e-05 | 65 | 50 | 4 | MM15147 | |
| Pathway | REACTOME_CREB3_FACTORS_ACTIVATE_GENES | 1.22e-04 | 5 | 50 | 2 | MM15513 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.27e-04 | 73 | 50 | 4 | MM14948 | |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 1.94e-04 | 32 | 50 | 3 | M29579 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 2.00e-04 | 82 | 50 | 4 | MM15394 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 2.13e-04 | 33 | 50 | 3 | M27016 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 2.19e-04 | 84 | 50 | 4 | MM14929 | |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 2.33e-04 | 34 | 50 | 3 | M27041 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 2.40e-04 | 86 | 50 | 4 | MM15413 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 2.54e-04 | 35 | 50 | 3 | M27320 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 2.76e-04 | 36 | 50 | 3 | M27245 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 2.76e-04 | 36 | 50 | 3 | M26974 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 3.00e-04 | 37 | 50 | 3 | M1029 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 3.00e-04 | 37 | 50 | 3 | M27038 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 3.11e-04 | 92 | 50 | 4 | MM14951 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 3.51e-04 | 39 | 50 | 3 | M27238 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 4.07e-04 | 41 | 50 | 3 | M29574 | |
| Pathway | REACTOME_CREB3_FACTORS_ACTIVATE_GENES | 4.37e-04 | 9 | 50 | 2 | M27773 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 4.69e-04 | 43 | 50 | 3 | M26975 | |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 5.02e-04 | 44 | 50 | 3 | M109 | |
| Pathway | REACTOME_SUMOYLATION | 5.34e-04 | 189 | 50 | 5 | M27214 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 5.72e-04 | 46 | 50 | 3 | M27397 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 6.10e-04 | 47 | 50 | 3 | M27395 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 7.01e-04 | 114 | 50 | 4 | MM15361 | |
| Pathway | REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR | 7.95e-04 | 12 | 50 | 2 | MM14981 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 8.68e-04 | 53 | 50 | 3 | M27212 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 9.17e-04 | 54 | 50 | 3 | M29594 | |
| Pathway | REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS | 1.19e-03 | 59 | 50 | 3 | M27606 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 1.39e-03 | 234 | 50 | 5 | MM14898 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 1.43e-03 | 16 | 50 | 2 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 1.62e-03 | 17 | 50 | 2 | M27412 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 1.79e-03 | 68 | 50 | 3 | MM14921 | |
| Pathway | REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT | 1.87e-03 | 69 | 50 | 3 | M27113 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | 1.91e-03 | 505 | 50 | 7 | MM15548 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 2.03e-03 | 71 | 50 | 3 | M27394 | |
| Pathway | REACTOME_ISG15_ANTIVIRAL_MECHANISM | 2.28e-03 | 74 | 50 | 3 | M48006 | |
| Pathway | REACTOME_M_PHASE | 2.36e-03 | 387 | 50 | 6 | MM15364 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN | 2.48e-03 | 21 | 50 | 2 | M27634 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.48e-03 | 21 | 50 | 2 | MM15706 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 2.55e-03 | 77 | 50 | 3 | M27226 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.97e-03 | 23 | 50 | 2 | M556 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 3.05e-03 | 82 | 50 | 3 | M27250 | |
| Pathway | REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT | 3.16e-03 | 83 | 50 | 3 | MM14819 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 3.27e-03 | 84 | 50 | 3 | M725 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 3.38e-03 | 85 | 50 | 3 | M1870 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 3.79e-03 | 26 | 50 | 2 | M27483 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 4.09e-03 | 27 | 50 | 2 | M29807 | |
| Pubmed | POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation. | 7.15e-09 | 3 | 68 | 3 | 30802453 | |
| Pubmed | 7.15e-09 | 3 | 68 | 3 | 35507432 | ||
| Pubmed | Two distinct human POM121 genes: requirement for the formation of nuclear pore complexes. | 2.86e-08 | 4 | 68 | 3 | 17900573 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 9.38e-07 | 38 | 68 | 4 | 12791264 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 3.10e-06 | 457 | 68 | 8 | 32344865 | |
| Pubmed | 3.20e-06 | 15 | 68 | 3 | 14697343 | ||
| Pubmed | The T-box transcription factors TBX2 and TBX3 in mammary gland development and breast cancer. | 3.77e-06 | 2 | 68 | 2 | 23624936 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 25394776 | ||
| Pubmed | Complex functional redundancy of Tbx2 and Tbx3 in mouse limb development. | 3.77e-06 | 2 | 68 | 2 | 35506352 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 23388722 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 30223900 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 10468588 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 23544943 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 25371204 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 5.74e-06 | 351 | 68 | 7 | 38297188 | |
| Pubmed | 1.07e-05 | 22 | 68 | 3 | 15843407 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 23053434 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 9196325 | ||
| Pubmed | LARP4B is an AU-rich sequence associated factor that promotes mRNA accumulation and translation. | 1.13e-05 | 3 | 68 | 2 | 26001795 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 30236127 | ||
| Pubmed | Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. | 1.13e-05 | 3 | 68 | 2 | 8988164 | |
| Pubmed | Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone. | 1.13e-05 | 3 | 68 | 2 | 17592322 | |
| Pubmed | Expression of Drosophila omb-related T-box genes in the developing human and mouse neural retina. | 1.13e-05 | 3 | 68 | 2 | 11726608 | |
| Pubmed | Molecular mechanisms of pituitary organogenesis: In search of novel regulatory genes. | 1.13e-05 | 3 | 68 | 2 | 20025935 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 35879412 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 16326862 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 12000749 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 11748239 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 27483328 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 24204560 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 24939955 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | LARP4B POM121 LMAN1 BAIAP2L1 INF2 ADAM15 SEC23IP ESPL1 POM121C DNMT1 | 1.42e-05 | 942 | 68 | 10 | 31073040 |
| Pubmed | 1.78e-05 | 418 | 68 | 7 | 34709266 | ||
| Pubmed | Tbx3 represses E-cadherin expression and enhances melanoma invasiveness. | 2.25e-05 | 4 | 68 | 2 | 18829543 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 22284968 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 8798150 | ||
| Pubmed | TRPV4 activation in human corneal epithelial cells promotes membrane mucin production. | 2.25e-05 | 4 | 68 | 2 | 39024979 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 2.47e-05 | 440 | 68 | 7 | 34244565 | |
| Pubmed | 3.45e-05 | 638 | 68 | 8 | 31182584 | ||
| Pubmed | 3.70e-05 | 469 | 68 | 7 | 27634302 | ||
| Pubmed | Expression of the T-box family genes, Tbx1-Tbx5, during early mouse development. | 3.75e-05 | 5 | 68 | 2 | 8853987 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 17173667 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 22002537 | ||
| Pubmed | Mouse thromboxane A2 receptor: cDNA cloning, expression and northern blot analysis. | 3.75e-05 | 5 | 68 | 2 | 1375456 | |
| Pubmed | 4.06e-05 | 653 | 68 | 8 | 22586326 | ||
| Pubmed | 4.47e-05 | 35 | 68 | 3 | 11013070 | ||
| Pubmed | 4.63e-05 | 486 | 68 | 7 | 20936779 | ||
| Pubmed | 4.81e-05 | 332 | 68 | 6 | 25693804 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 20850414 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 16222716 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 23661717 | ||
| Pubmed | Lack of genetic interaction between Tbx20 and Tbx3 in early mouse heart development. | 5.62e-05 | 6 | 68 | 2 | 23936153 | |
| Pubmed | Uncoupling Sonic hedgehog control of pattern and expansion of the developing limb bud. | 5.62e-05 | 6 | 68 | 2 | 18410737 | |
| Pubmed | RBP-Jkappa/SHARP recruits CtIP/CtBP corepressors to silence Notch target genes. | 5.62e-05 | 6 | 68 | 2 | 16287852 | |
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 5.62e-05 | 6 | 68 | 2 | 25930072 | |
| Pubmed | Evolution of mouse T-box genes by tandem duplication and cluster dispersion. | 5.62e-05 | 6 | 68 | 2 | 8878690 | |
| Pubmed | RIP140 directs histone and DNA methylation to silence Ucp1 expression in white adipocytes. | 5.62e-05 | 6 | 68 | 2 | 17972916 | |
| Pubmed | 5.74e-05 | 38 | 68 | 3 | 11779826 | ||
| Pubmed | 5.74e-05 | 38 | 68 | 3 | 30201295 | ||
| Pubmed | 5.93e-05 | 107 | 68 | 4 | 30995489 | ||
| Pubmed | TBX3 LARP4B CECR2 MACROH2A2 ZNF318 GPR108 ANKHD1 POM121C TRIM24 TBX2 | 5.97e-05 | 1116 | 68 | 10 | 31753913 | |
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 22203979 | ||
| Pubmed | Expression of Tbx2 and Tbx3 in the developing hypothalamic-pituitary axis. | 7.86e-05 | 7 | 68 | 2 | 18534921 | |
| Pubmed | Tbx1 affects asymmetric cardiac morphogenesis by regulating Pitx2 in the secondary heart field. | 7.86e-05 | 7 | 68 | 2 | 16556915 | |
| Pubmed | 9.09e-05 | 733 | 68 | 8 | 34672954 | ||
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | 9.41e-05 | 375 | 68 | 6 | 32788342 | |
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 9503012 | ||
| Pubmed | Ihh and Runx2/Runx3 signaling interact to coordinate early chondrogenesis: a mouse model. | 1.05e-04 | 8 | 68 | 2 | 23383321 | |
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 7920656 | ||
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 28317850 | ||
| Pubmed | Dynamic expression of Tbx2 and Tbx3 in developing mouse pancreas. | 1.05e-04 | 8 | 68 | 2 | 21867776 | |
| Pubmed | 1.05e-04 | 963 | 68 | 9 | 28671696 | ||
| Pubmed | 1.27e-04 | 396 | 68 | 6 | 26687479 | ||
| Pubmed | Msx1 and Msx2 are functional interacting partners of T-box factors in the regulation of Connexin43. | 1.68e-04 | 10 | 68 | 2 | 18285513 | |
| Pubmed | 1.68e-04 | 10 | 68 | 2 | 25487574 | ||
| Pubmed | Transcription is required for establishment of germline methylation marks at imprinted genes. | 1.68e-04 | 10 | 68 | 2 | 19136628 | |
| Pubmed | Dynamic expression of Tbx2 subfamily genes in development of the mouse reproductive system. | 1.68e-04 | 10 | 68 | 2 | 22223620 | |
| Pubmed | 1.68e-04 | 10 | 68 | 2 | 17519333 | ||
| Pubmed | 1.68e-04 | 263 | 68 | 5 | 34702444 | ||
| Pubmed | 1.77e-04 | 808 | 68 | 8 | 20412781 | ||
| Pubmed | 2.05e-04 | 11 | 68 | 2 | 17668378 | ||
| Pubmed | Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation. | 2.05e-04 | 11 | 68 | 2 | 8954725 | |
| Pubmed | Tbx Genes Specify Posterior Digit Identity through Shh and BMP Signaling. | 2.05e-04 | 11 | 68 | 2 | 14723846 | |
| Pubmed | 2.05e-04 | 11 | 68 | 2 | 8406478 | ||
| Pubmed | Accumulation of AMPA receptors in autophagosomes in neuronal axons lacking adaptor protein AP-4. | 2.05e-04 | 11 | 68 | 2 | 18341993 | |
| Pubmed | Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription. | 2.15e-04 | 59 | 68 | 3 | 28813667 | |
| Pubmed | The molecular basis of Pallister Hall associated polydactyly. | 2.45e-04 | 12 | 68 | 2 | 17588959 | |
| Pubmed | 2.45e-04 | 12 | 68 | 2 | 37143315 | ||
| Pubmed | ISL1 regulates lung branching morphogenesis via Shh signaling pathway. | 2.45e-04 | 12 | 68 | 2 | 37442233 | |
| Pubmed | SPOP targets oncogenic protein ZBTB3 for destruction to suppress endometrial cancer. | 2.45e-04 | 12 | 68 | 2 | 31911863 | |
| Pubmed | 2.56e-04 | 288 | 68 | 5 | 23383273 | ||
| Pubmed | Expression of Slit and Robo genes in the developing mouse heart. | 2.90e-04 | 13 | 68 | 2 | 20941780 | |
| Pubmed | 2.90e-04 | 13 | 68 | 2 | 12668638 | ||
| Pubmed | 2.90e-04 | 13 | 68 | 2 | 25599332 | ||
| Pubmed | Loss of Tbx2 delays optic vesicle invagination leading to small optic cups. | 3.38e-04 | 14 | 68 | 2 | 19576202 | |
| Pubmed | 3.38e-04 | 14 | 68 | 2 | 18467625 | ||
| Pubmed | 3.89e-04 | 15 | 68 | 2 | 25453830 | ||
| Pubmed | Twist1 activity thresholds define multiple functions in limb development. | 3.89e-04 | 15 | 68 | 2 | 20732316 | |
| Pubmed | 4.44e-04 | 16 | 68 | 2 | 27856909 | ||
| Pubmed | Lack of Genetic Interaction between Tbx18 and Tbx2/Tbx20 in Mouse Epicardial Development. | 4.44e-04 | 16 | 68 | 2 | 27253890 | |
| Cytoband | 19p13.2 | 1.22e-06 | 229 | 68 | 6 | 19p13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 2.35e-05 | 797 | 68 | 8 | chr19p13 | |
| Cytoband | 7q11.23 | 4.15e-04 | 97 | 68 | 3 | 7q11.23 | |
| Cytoband | 3p22.1 | 1.63e-03 | 40 | 68 | 2 | 3p22.1 | |
| Cytoband | 1p36 | 2.24e-03 | 47 | 68 | 2 | 1p36 | |
| GeneFamily | La ribonucleoprotein domain containing|RNA binding motif containing | 1.10e-04 | 7 | 42 | 2 | 625 | |
| GeneFamily | T-boxes | 7.87e-04 | 18 | 42 | 2 | 766 | |
| GeneFamily | CD molecules|Mucins | 1.08e-03 | 21 | 42 | 2 | 648 | |
| GeneFamily | Nucleoporins | 2.50e-03 | 32 | 42 | 2 | 1051 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 5.95e-03 | 718 | 42 | 6 | 28 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.07e-07 | 186 | 68 | 6 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.24e-06 | 157 | 68 | 5 | 84f629b7f589ca8a1abc220fa740c4a6fdc1b579 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.02e-06 | 179 | 68 | 5 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 8.93e-06 | 183 | 68 | 5 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.17e-06 | 184 | 68 | 5 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 189 | 68 | 5 | 32e6d6285b258831b965281224ff2aaeecdcb5f5 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 189 | 68 | 5 | 385ef7bbd76c8047aeecf6542377d4213b5da5db | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.10e-05 | 191 | 68 | 5 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.15e-05 | 193 | 68 | 5 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.27e-05 | 197 | 68 | 5 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 1.27e-05 | 197 | 68 | 5 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-05 | 198 | 68 | 5 | 148f5fee19ea8dff7f2de4ca69c3b03e5221985d | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.37e-05 | 200 | 68 | 5 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | critical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.37e-05 | 200 | 68 | 5 | f39db4250ce220a3eb58edee3f7fc3671701d46f | |
| ToppCell | Parenchymal-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 200 | 68 | 5 | 4e5b6cb014d9bcb58e13c7511c86c43e27c496e4 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.70e-05 | 130 | 68 | 4 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.09e-05 | 139 | 68 | 4 | 2fdc8f36510aff24abbc79ef2a842db75a85f946 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.09e-05 | 139 | 68 | 4 | 5970a654c64e3b54f9d18c102f5b125eec892fc5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.80e-05 | 143 | 68 | 4 | 8f897278f9ccc82ae35e4f30c5f930b2a3eb509d | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.75e-05 | 54 | 68 | 3 | 68c762094ea29e321a6fd4f6d9b598431023fa7b | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.75e-05 | 54 | 68 | 3 | 7816e6541e3a9e702f25bd102a95ce963ce31535 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.40e-05 | 151 | 68 | 4 | f13a117ae26ae525da4f3e837d8f204d00dc6ee3 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-05 | 151 | 68 | 4 | ced4f7ee377a23a804ae6fde624e8b55b79f1fd8 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-05 | 151 | 68 | 4 | b52bb3b88e9a6473f571053537b8beb418678539 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-04 | 160 | 68 | 4 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-04 | 160 | 68 | 4 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.33e-04 | 170 | 68 | 4 | aabe993c9f337b1caaeb0e64626a3920579c41b7 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.C1ql3_(VTA_(dorsal_VTA))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.35e-04 | 65 | 68 | 3 | 4382d56d5f71c7acfe35f84db7257aba2a7dd36a | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.C1ql3_(VTA_(dorsal_VTA))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.35e-04 | 65 | 68 | 3 | 05b712f83d88e864747cd0229a39aca17321e0f8 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-04 | 174 | 68 | 4 | 4da79da7a09ee1e345102c5331675ebcdbe56171 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.55e-04 | 177 | 68 | 4 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.65e-04 | 180 | 68 | 4 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 1.65e-04 | 180 | 68 | 4 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.65e-04 | 180 | 68 | 4 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 181 | 68 | 4 | 1db1eb7d330a7e5090994007ae287e11f0a74450 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 181 | 68 | 4 | 06174ce9240c9261c0f51a1b0d875335d60722e5 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-04 | 182 | 68 | 4 | 17ed11a7ea366dd3106400511d5e628d3f1a9c3e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.76e-04 | 183 | 68 | 4 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.80e-04 | 184 | 68 | 4 | 7712f2e1fae5cdde2d4e355b860dc8536b28e4f6 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 1.80e-04 | 184 | 68 | 4 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 1.83e-04 | 185 | 68 | 4 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-04 | 185 | 68 | 4 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.83e-04 | 185 | 68 | 4 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-04 | 185 | 68 | 4 | fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-04 | 185 | 68 | 4 | 929b68b05b7686341329ac756d7df172cb4b810b | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-04 | 186 | 68 | 4 | b58db5abdd3e9f0214b198c3cbd09b0b3c321eab | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-04 | 186 | 68 | 4 | cd6502bbf9dce318fdbb4965d49df8951e5f795c | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 73 | 68 | 3 | 3ac392ac46ad577c7d2c2b5e6a0a96ceb613097b | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 73 | 68 | 3 | 1bd6ff9659efc43b0a596da50e325bde2f0ba8f7 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-04 | 187 | 68 | 4 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.91e-04 | 187 | 68 | 4 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.91e-04 | 187 | 68 | 4 | b827d9da7032bf051756ddf88352af922eb0f87b | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.91e-04 | 187 | 68 | 4 | 61c00604dda8b36a5c3eea6554e5601aa1b884f7 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.95e-04 | 188 | 68 | 4 | 6164d467b612767ceba15de34176bcc8e8c36ab8 | |
| ToppCell | LAM-Endothelial-VasEndo-1|Endothelial / Condition, Lineage and Cell class | 1.95e-04 | 188 | 68 | 4 | f24c33d960ca93459584a79ff8f0ec20db6a34d5 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.95e-04 | 188 | 68 | 4 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.95e-04 | 188 | 68 | 4 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | E12.5-Mesenchymal|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.95e-04 | 188 | 68 | 4 | 9778dadc2bd7ded3a723e717d1c8cd3160e99c6c | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.95e-04 | 188 | 68 | 4 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 1.99e-04 | 189 | 68 | 4 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.99e-04 | 189 | 68 | 4 | 815afad947ed77a8b03724bf78014799fed34f54 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.99e-04 | 189 | 68 | 4 | 3169476f98b7385706cb618c9ad64ae83a290ef0 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.07e-04 | 191 | 68 | 4 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.07e-04 | 191 | 68 | 4 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.11e-04 | 192 | 68 | 4 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 2.11e-04 | 192 | 68 | 4 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.11e-04 | 192 | 68 | 4 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.11e-04 | 192 | 68 | 4 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.16e-04 | 193 | 68 | 4 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-04 | 193 | 68 | 4 | 5879efb38e6b3bf8c33c9a773632b1d726e3c153 | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.16e-04 | 193 | 68 | 4 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 2.16e-04 | 193 | 68 | 4 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-04 | 193 | 68 | 4 | 725115a5ce3ef520b3ef469e96b8219b4c723fdd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft-Tuft_L.0.7.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-04 | 193 | 68 | 4 | abd7bcf318a2d895d8811c2ada8bfb4314fca3b1 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.16e-04 | 193 | 68 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.16e-04 | 193 | 68 | 4 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 2.16e-04 | 193 | 68 | 4 | c0d4da15d973cf6f8daa2b0af84b1baaf8491b83 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-04 | 194 | 68 | 4 | af4bbb2deb5a3913eb58990690fc3c62fbc3708c | |
| ToppCell | P15-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.20e-04 | 194 | 68 | 4 | 5f04d21c4e2d36e74b6c5889aa97fd98f75a0973 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 2.20e-04 | 194 | 68 | 4 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-04 | 195 | 68 | 4 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-04 | 196 | 68 | 4 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.29e-04 | 196 | 68 | 4 | 028a06ed92f1c058dcbeacd335625bf529e87a7b | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.29e-04 | 196 | 68 | 4 | 2a885eed52f9b002c7995e11e450c7e8d7ae69e6 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.29e-04 | 196 | 68 | 4 | 14246f00c90741a5f8683f377e22e3a7c99661b9 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.33e-04 | 197 | 68 | 4 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.33e-04 | 197 | 68 | 4 | 1da8ba5bbab232add6e43ad78b15c2339d0c2bc3 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.33e-04 | 197 | 68 | 4 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.33e-04 | 197 | 68 | 4 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.38e-04 | 198 | 68 | 4 | d087e738d69ca9853553fde46d4e7a8906439d32 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.38e-04 | 198 | 68 | 4 | 691a2f1779225e5519155460eeb6a2aac5f67a92 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.38e-04 | 198 | 68 | 4 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.38e-04 | 198 | 68 | 4 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.38e-04 | 198 | 68 | 4 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.38e-04 | 198 | 68 | 4 | aa80315395cb5dffc25927c8a77cd2037aea8772 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.38e-04 | 198 | 68 | 4 | aed0476248e9637897eefb1623ec4035f2dacd82 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.38e-04 | 198 | 68 | 4 | e115eea04012e9e492e923ed080e1723c38d14fd | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.38e-04 | 198 | 68 | 4 | 33d1e0b6f57663544bee0ffdde83a65da764d44c | |
| ToppCell | Severe_COVID-19-Epithelial-AT1/AT2|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.38e-04 | 198 | 68 | 4 | 43e33d28d9de5033bd00d39be953542a225236ed | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.38e-04 | 198 | 68 | 4 | cc162ba4b3b8dec667a8cffd3411965f3f856f8c | |
| Disease | testosterone measurement | BMP5 CYP3A7 NF1 BAIAP2L1 CECR2 SEC23IP XDH PLAGL1 ZNF318 LARP4 MAPK10 | 1.30e-04 | 1275 | 67 | 11 | EFO_0004908 |
| Disease | nucleus accumbens volume change measurement | 2.76e-04 | 11 | 67 | 2 | EFO_0021493 | |
| Disease | alkaline phosphatase measurement | NF1 POM121 BAIAP2L1 GLIS2 ZNF318 TNFRSF11A STKLD1 CNOT1 DNMT1 | 4.65e-04 | 1015 | 67 | 9 | EFO_0004533 |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 6.76e-04 | 17 | 67 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | etiocholanolone glucuronide measurement | 8.47e-04 | 19 | 67 | 2 | EFO_0800362 | |
| Disease | pancreatic cancer (is_marker_for) | 1.59e-03 | 101 | 67 | 3 | DOID:1793 (is_marker_for) | |
| Disease | Developmental Academic Disorder | 1.98e-03 | 29 | 67 | 2 | C1330966 | |
| Disease | Learning Disorders | 1.98e-03 | 29 | 67 | 2 | C0023186 | |
| Disease | Learning Disturbance | 1.98e-03 | 29 | 67 | 2 | C0751263 | |
| Disease | Adult Learning Disorders | 1.98e-03 | 29 | 67 | 2 | C0751262 | |
| Disease | Learning Disabilities | 1.98e-03 | 29 | 67 | 2 | C0751265 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PLGPATQVPALFSAA | 26 | Q8N616 | |
| PFSFSQGPLKDAPNL | 296 | Q13363 | |
| FALIILPSISPFGPN | 331 | Q68CJ9 | |
| LPPEAFTFNIKLSSP | 941 | P26358 | |
| RGTKQASALSFPAPP | 756 | Q13444 | |
| FSVKQNPLPSSFPGK | 161 | Q8IUR6 | |
| LKSVAFPPFPSGRNC | 306 | Q9P0M6 | |
| PELPKTSSFAASGPL | 586 | Q9Y6B7 | |
| GPLFTFKLLTEPESP | 471 | P35368 | |
| VPAPSSLFGAPAQAL | 876 | Q9BXF3 | |
| QPSPQASFLPGFGVK | 466 | Q6PCD5 | |
| PTTAGPLLVPFTLNF | 12691 | Q8WXI7 | |
| DFTSPLFKPATGFPL | 4336 | Q99102 | |
| GLTFPKLFPDSLFPA | 306 | P53779 | |
| GAAPFKAPPSVVFLA | 1176 | Q6ZU64 | |
| NGFTSPAFKPAASPL | 386 | Q92615 | |
| LSSFPPLPGAAGNLK | 531 | Q92615 | |
| FAKPSLSAQPGPAVS | 111 | Q9HCN6 | |
| SFLTFQLTEPGKEPP | 261 | P49257 | |
| SPGSPPSGFLLNSKF | 51 | Q9BZE0 | |
| LKPLKFSSNQPPAAG | 1111 | Q27J81 | |
| SAPSPAPKQSFLFGT | 671 | A8CG34 | |
| FQFGKPPALPTTTTV | 466 | A6NF01 | |
| TFNIPFGSSAKSPLP | 531 | A6NF01 | |
| LSIFDPPPFKVTLTG | 111 | Q9Y6W8 | |
| ASAPFNFTLPPNFGK | 6 | Q14973 | |
| QATSAPSPAPKQSFL | 691 | Q96HA1 | |
| IFQFGKPPALPTTTT | 881 | Q96HA1 | |
| PTFNIPFGSSAKSPL | 946 | Q96HA1 | |
| LKEFLSNPPAGFPSS | 26 | Q14674 | |
| AKPPFLSGENPFATV | 481 | Q9UHR4 | |
| NSSLPDKLPIFPDSA | 6 | Q9NQ33 | |
| RPFSPGKQASSAPLF | 66 | P22003 | |
| KFDLLASNFPPLPGS | 476 | Q71RC2 | |
| SALEKPNGATPVFNP | 271 | Q9NUK0 | |
| PTPLPFLGNALSFRK | 41 | P24462 | |
| PQKSKPGVFSFLDPL | 521 | P42261 | |
| DLSQPPFSKSGRSFP | 281 | P0C7I6 | |
| LFFPLNSIPTPLSGQ | 461 | Q8WY07 | |
| LSSPFDLNFPLPGEK | 221 | Q9BTE3 | |
| GFNKPAASATPFALP | 111 | Q9BVL2 | |
| SFQLKAAALPPFPLG | 231 | Q9UM63 | |
| FPALTLPPNGAAALS | 41 | O15119 | |
| SSFPVLSPAFPSLIK | 501 | Q5VVP1 | |
| NSAFPLAALPQPGLS | 476 | Q9H6K5 | |
| TLFIFPGLLPEAPSK | 136 | Q9NPR9 | |
| DLSKKFPQLGATPFP | 126 | Q96QH2 | |
| APKALATGPNSPELF | 51 | Q2NL68 | |
| NAFSPSISKAQPGAP | 131 | Q9Y6Y8 | |
| GAPGFPPQLLSSFIK | 4671 | Q9P2P6 | |
| LNSGVSSNKLPSFPP | 1546 | Q9UHV7 | |
| FAENGPSQKSSLPPL | 81 | Q9UJM3 | |
| SEPSLLEFKPFSNGP | 476 | Q96QV1 | |
| ANKSLPPTFGPATLF | 2196 | Q8IWZ3 | |
| GSAFSTPQSPAKAFP | 741 | A5YKK6 | |
| QPPSGLSSNQLSKFP | 446 | O15164 | |
| LDAKPPTPGASFSQA | 1731 | Q96T58 | |
| SFPVLSPAFPSLIKN | 506 | Q5TZJ5 | |
| SFFPALALPPGALAK | 36 | Q13207 | |
| LVSDSSAFSKPGLPP | 651 | Q8NE28 | |
| LLFNPSKPFSRGSQP | 356 | P21359 | |
| PTFASATLLFQKDPP | 541 | P47989 | |
| LPGNFSFTPKVIPDS | 936 | P08922 | |
| APQGSNSKTPIFSPF | 861 | Q9Y2I9 | |
| NVSSVVKPSFLPLPF | 421 | Q08AG5 | |
| RNPSFKPAPALSAAG | 446 | Q9H8Y1 | |
| ASASSDAPPFQLGKP | 16 | Q8TD22 | |
| DLAFPGKSSLQSPNP | 541 | Q8N2I2 | |
| PSFSGFPLDSPKTLV | 2066 | Q5VUA4 | |
| GAVASLAAFPFPKPA | 6 | Q6ZS27 | |
| LFLTEPGSKSTPPFS | 361 | Q9Y6Q6 | |
| SPKAIPNGFGTSPLT | 231 | Q9GZM8 |